SCHEMBL23706996

SCHEMBL23706996

CCN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 6/20 0.78
▸ HRH1 P35367 5/20 0.78
▸ CHRM2 P08172 4/20 0.78
▸ ADRA2A P08913 4/20 0.78
▸ CHRM1 P11229 4/20 0.78
▸ DRD1 P21728 4/20 0.78
▸ LMNA P02545 3/20 0.78
▸ ADRA2B P18089 3/20 0.78
▸ HTR2A P28223 3/20 0.78
▸ HTR2C P28335 3/20 0.78
▸ HTR3A P46098 3/20 0.78
▸ ADRA1A P35348 3/20 0.78
▸ KCNH2 Q12809 3/20 0.78
▸ CYP2D6 P10635 3/20 0.78
▸ CYP2C19 P33261 3/20 0.78
▸ CHRM4 P08173 2/20 0.78
▸ CHRM5 P08912 2/20 0.78
▸ CHRM3 P20309 2/20 0.78
▸ HTR6 P50406 2/20 0.78
▸ HRH4 Q9H3N8 2/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ketotifen SCHEMBL29356083 0.88 DRD3 (1.00) DRD3HRH1CHRM2ADRA2ACHRM1
Ketotifen SCHEMBL223510 0.88 DRD3 (1.00) DRD3HRH1CHRM2ADRA2ACHRM1
Ketotifen SCHEMBL4436 0.88 DRD3 (1.00) DRD3HRH1CHRM2ADRA2ACHRM1
Ketotifen SCHEMBL1171289 0.87 DRD3 (0.97) DRD3HRH1CHRM2ADRA2ACHRM1
Ketotifen SCHEMBL3386047 0.87 DRD3 (0.97) DRD3HRH1CHRM2ADRA2ACHRM1
Ketotifen SCHEMBL1170804 0.87 DRD3 (0.97) DRD3HRH1CHRM2ADRA2ACHRM1
Ketotifen SCHEMBL28259803 0.86 DRD3 (0.95) DRD3HRH1CHRM2ADRA2ACHRM1
SCHEMBL9844262 0.85 DRD3 (0.70) DRD3HRH1CHRM2ADRA2ACHRM1
SCHEMBL9844494 0.85 DRD3 (0.66) DRD3HRH1CHRM2ADRA2ACHRM1
SCHEMBL9844340 0.84 DRD3 (0.72) DRD3HRH1CHRM2ADRA2ACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858354-A1 SYNERGIC PHARMACEUTICAL COMBINATION OF A LEUKOTRIENE-RECEPTOR ANTAGONIST AND AN INVERSE AGONIST OF HISTAMINE H1 Amézcua Amézcua, Federico (MX) 2021-08-04 — — EP disclosed
Send feedback